Search by Category
Search in Packages
Search by Format
Search by Type
Search by Date Range
Products are filtered by different dates, depending on the combination of live and on-demand components that they contain, and on whether any live components are over or not.
Search by Keyword
Sort By
  • Contains 2 Component(s)

    As part of the MRF’s 2023 #MucosalMelanomaAwareness month campaign entitled #OutOfTheShadows, we highlight two mucosal melanoma patient advocates, JB Ward and Cristian Jonsson, who delivered remarks at the 2022 Increasing Collaboration Amongst the Mucosal Melanoma Community meeting. *This webinar was recorded in 2022.


    J.B. Ward, PhD

    Mucosal Melanoma Patient Advocate

    Cristian Jonsson

    Mucosal Melanoma Patient Advocate

  • Contains 2 Component(s)

    Learn more about how the patient voice is incorporated and can be the center of OM research. *This was recorded in 2022


    Nigel Deacon

    OM Patient

    Ocumel Canada

    Nigel Deacon is the co-founder of Ocumel Canada, an initiative of Save Your Skin Foundation in Canada. He retired from a career in public education in 2012 when he was diagnosed with metastatic ocular melanoma. He now devotes his time to improving outcomes for Canadian OM patients. Ocumel Canada was founded in January 2019 and you can find out more at Nigel also is a member of the CURE OM Steering Committee.

    Sara Selig, MD, MPH

    Co-Founder & Director, CURE OM

    MRF's CURE OM Initiative

    Dr. Sara Selig is the Co-Founder and Director of the MRF’s CURE OM initiative. Sara initially became involved with the OM community when her husband, Gregg, was diagnosed with the disease in 2006, at the age of 34, when Sara was a fourth year medical student. At the time of Gregg’s diagnosis, Gregg and Sara became fierce advocates for Gregg’s care and the entire OM community as well. Sara continues to be a passionate advocate for the ocular melanoma field—working to accelerate research, promote collaboration, and support patients and caregivers through her leadership of the CURE OM initiative. She is currently Associate Physician in the Department of Internal Medicine, Division of Global Health Equity at Brigham and Women’s Hospital and an Instructor in Medicine at Harvard Medical School.

    Basil K. Williams, Jr., MD

    Ocular Oncologist and Vitreoretinal Surgeon

    Bascom Palmer Eye Institute

    Basil K. Williams Jr., MD is an ocular oncologist and vitreoretinal surgeon at the Bascom Palmer Eye Institute, where he completed his ophthalmology residency and vitreoretinal surgery fellowship and served as a chief resident and co-director of ocular trauma. During this time, he was inducted into the Alpha Omega Alpha Honor Society and won the Fellow of the Year Award. He completed an additional fellowship in ocular oncology at Wills Eye Hospital, where he received the William Tasman Outstanding Fellow Teaching Award. He grew up in the Bronx, NY and received his Bachelor of Arts Degree from Yale University. He then attended The Chicago Medical School where he was elected to the Gold Humanism Honor Society. Prior to joining Bascom Palmer, he was the Director of Ocular Oncology at the University of Cincinnati and held the Mary Knight Asbury Endowed Chair of Ocular Oncology.  

  • Contains 2 Component(s)

    Learn more about liver-directed therapies for metastatic OM patients. *This was recorded in 2022


    Sapna Patel, MD

    Director of the Uveal Melanoma Program and Associate Professor

    The University of Texas MD Anderson Cancer Center

    Dr. Patel is an Associate Professor, Fellowship Program Director, and Director of the Uveal Melanoma Program in the Department of Melanoma Oncology at MD Anderson Cancer Center.  She is also Chair of the SWOG Melanoma Committee.

    In these roles, she serves as lead physician for the uveal melanoma trials at MD Anderson including numerous investigator-initiated and sponsored clinical trials as well as Project 3 Co-Leader for the Melanoma SPORE.  She is also national Study Chair of SWOG S1801 and S1404 trials, the largest melanoma trials investigating neoadjuvant and adjuvant checkpoint blockade for cutaneous melanoma.

    She has authored over 88 peer-reviewed manuscripts and book chapters, more than 28 as first or senior author.  Her grant work focuses on translational research, for which she has received at least 8 independent intramural and extramural funding awards as PI from the NIH/NCI, DOD, Melanoma SPORE, and MD Anderson Institutional Research Grants and Multidisciplinary Research Program award.  The goals of Dr. Patel’s work are to translate the findings into effective monitoring and therapeutic strategies for patients with melanoma. 

    Dr. Eric Wehrenberg-Klee

    Director of Center for Image Guided Cancer Therapy; Interventional Radiologist

    Massachusetts General Hospital

    Dr. Eric Wehrenberg-Klee is an interventional radiologist at Massachusetts General Hospital in Boston, MA where he is the Director of the Center for Image-Guided Cancer Therapy, as well as an Assistant Professor of Radiology at Harvard Medical School.  He is the primary investigator on multiple investigator initiated and industry sponsored trials evaluating the role of minimally invasive interventional procedures for the treatment of cancer.  His laboratory work focus on the immune response to local tumor therapies and their synergy with checkpoint inhibition and is sponsored by grant funding from the National Cancer Institute.  

    Steven Katz, MD

    Chief Medical Officer

    TriSalus Life Sciences

    Dr. Steven Katz joined TriSalus in 2018 as Chief Medical Advisor and Chairman of the Scientific Advisory Boards. In September 2020, Steven became the first Chief Medical Officer of TriSalus. Previously, as a full-time academic surgical oncologist, he developed a reputation as a leader in solid tumor immunotherapy, cellular therapeutics, cancer biology, liver immunology and execution of immunotherapy clinical trials. His laboratory has focused on studying liver immunosuppressive cells and strategies for enabling immunotherapy in liver tumors. He also currently serves as Associate Professor of Surgery at the Warren Alpert Medical School of Brown University. His clinical expertise is in surgical therapy and multi-disciplinary management of liver tumors, pancreas tumors, sarcoma and melanoma. 


  • Contains 11 Product(s)

    This course for the healthcare student does a deep dive into melanoma prevention, diagnosis, and treatment, as well as provides information on how melanoma may appear in the BIPOC population and information about the rare melanoma subtypes.


  • Contains 1 Component(s)

    This course will provide an introductory understanding of how to advocate to your government officials for melanoma priorities.

  • Contains 2 Component(s)

    This course is for anyone who would like to learn more about types of melanoma, what melanoma may look like, and strategies to prevent melanoma.

  • Contains 2 Component(s)

    Learn more about moles in children and adolescents. *This presentation was recorded in 2022.


    Elena B. Hawryluk, MD, PhD

    Pediatric Dermatologist

    Massachusetts General Hospital, Boston Children's Hospital

    Dr. Elena Hawryluk is a board-certified Dermatologist and Pediatric Dermatologist, and Associate Professor of Dermatology at Harvard Medical School, where she serves as the Faculty Director of Pediatric Dermatology for the Harvard Combined Dermatology Residency Program. Dr. Hawryluk cares for patients at Massachusetts General Hospital and Boston Children's Hospital, and has a clinical and research interest in pigmented lesions and melanoma in the pediatric population. She has numerous publications and national and international invited presentations on the care of children with congenital nevi, pigmented lesions, and melanoma. 

  • Contains 2 Component(s)

    Learn more about why research is important for pediatric melanoma. *This presentation was recorded in 2022.


    Brittani Seynnaeve, MD

    Pediatric Hematology Oncology

    UPMC Children’s Hospital of Pittsburgh

    Dr. Seynnaeve received her Bachelor of Science degree from University of Pittsburgh, graduating summa cum laude with a major in molecular biology and minor in chemistry in 2007. She received her Medical Degree from West Virginia University School of Medicine in 2011 having earned accolades including Alpha Omega Alpha and the Ferrari Pediatrics Scholar Award.  Dr. Seynnaeve then completed her Pediatric Residency training at UPMC Children’s Hospital of Pittsburgh from 2011 to 2014 having earned the UPMC Children’s Hospital of Pittsburgh Pediatric Residency Foundation Scholarship.  She pursued subspecialty training in Pediatric Hematology/Oncology at UPMC Children’s Hospital of Pittsburgh, completing her fellowship in 2017.  She obtained a Masters of Science Degree in Clinical Research at the University of Pittsburgh during her fellowship and also completed a post-doctoral T32 training program in skin biology and cancer at the University of Pittsburgh Cancer Institute while conducting pediatric melanoma research, for which she also earned a CureRock Trainee Research Award.  Dr. Seynnaeve joined the Division of Pediatric Hematology/Oncology (PHO) as an Assistant Professor of Pediatrics at the University of Pittsburgh School of Medicine and UPMC Children’s Hospital of Pittsburgh in 2017.

    Dr. Seynnaeve cares for children with a broad array of hematology and oncology diagnoses, though has a specific clinical interest and expertise in pediatric melanoma. She is Clinical Director of the Pediatric Melanoma Center which she established as a multidisciplinary team approach at UPMC Children’s Hospital of Pittsburgh to care for patients diagnosed with melanoma and associated melanocytic tumors.  She is active in collaborative research serving as Principal Investigator the first pediatric melanoma clinical trial to open at UPMC which also serves as the first US site to offer patient enrollment for an international, multicenter study.  She is also active in medical education serving as the Associate Fellowship Program Director of the Pediatric Hematology/Oncology fellowship program.

  • Contains 2 Component(s)

    Watch the annual OM patient and caregiver symposium, hosted in a hybrid format at Sidney Kimmel Cancer Center at Jefferson Health. This video is part 4 of 4, with a focus on Psychosocial aspects. *This was recorded in August 2022


    Molly Vocino, MSW, LCSW

    Oncology Social Worker

    Sidney Kimmel Cancer Center of Jefferson Health

    Molly Vocino, MSW, LCSW, is an oncology social worker at the Sidney Kimmel Cancer Center of Jefferson Health in Philadelphia, Pennsylvania. She completed her graduated studies in social work at the University of Pennsylvania in 2016 and has been living and working in Philadelphia since that time. Prior to working in oncology, she supported hospice and palliative care patients in the community and in hospital settings and received a certification as an End-of-Life Doula from the University of Vermont in 2018. Currently, she works with the melanoma population at Jefferson and co-facilitates a monthly ocular melanoma support group in conjunction with the Melanoma Research Foundation.

    Gregory D. Garber, MSW, LCSW

    Director, Oncology Support Services

    Sidney Kimmel Cancer Center of Jefferson Health

    Greg Garber is a Licensed Clinical Social Worker and Director of Patient Support Services for Supportive Medicine and Cancer Survivorship at the Sidney Kimmel Cancer Center (SKCC), In that role he manages all patient facing programs and services including Patient Education and Support Programming, Clinical Nutrition Support, Social Work Services, and numerous initiatives to better understand and address cancer disparities as they relate to health literacy, digital literacy, access, transportation, cancer screening and prevention. Greg has lectured and taught on local regional and national levels on issues related to psychosocial aspects of cancer care and have presented at numerous national conferences including ASCO, APOS, AOSW, APHA. Greg is engaged in ongoing research related to delivery of supportive medicine and survivorship programming, shared decision-making, digital and health literacy, medical marijuana in oncology populations and lung cancer screening in underserved populations. Greg has extensive experience implementing supportive services for patients with cancer throughout their care trajectory. Additionally, Greg co-directs SKCC’s Patient and Family Advisory Council.

  • Contains 2 Component(s)

    Watch the annual OM patient and caregiver symposium, hosted in a hybrid format at Sidney Kimmel Cancer Center at Jefferson Health. This video is part 3 of 4, with a focus on Psychosocial aspects. *This was recorded in August 2022


    Ramona Sitko, MSW, LSW, ACHP-SW

    Oncology Social Worker

    Sidney Kimmel Cancer Center of Jefferson Health

    Ramona Sitko, MSW, LSW, is an oncology social worker at the Sidney Kimmel Cancer Center of Jefferson Health in Philadelphia, Pennsylvania. She completed her graduate studies in social work at the University of Pennsylvania in 1989.  Prior to joining the Sidney Kimmel Cancer Center, she worked at Abington-Jefferson Health providing hospice and palliative care services to individuals at home and the inpatient acute care settingDuring that time, she completed her Advanced Certification in Hospice and Palliative Care in 2016 and has also initiated a home-based palliative care service program which focused on goals of care and advanced care planning.  Currently she is part of the outpatient Supportive Oncology team at Jefferson.   

    Miriam Pomerantz Kadosh, MSW, LCSW

    Oncology Social Worker

    Sidney Kimmel Cancer Center of Jefferson Health

    Miriam Pomerantz Kadosh, MSW, LCSW is an oncology social worker at the Sidney Kimmel Cancer Center. Miriam works at the Cancer support and Welcome Center where she develops and evaluates patient and family programming including support groups, wellness programs and education sessions. She is a graduate of the University of Pennsylvania’s School of Social Policy and Practice with a Master’s in Social Work. Miriam is a co-facilitator of the Patient and Family advisory council, co-manages the Buddy peer match program and is an active member of the Schwartz Rounds planning committee creating a safe space for healthcare providers to talk about the human side of healthcare.